Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Interim Management Statement

15 May 2012 07:00

RNS Number : 3180D
Tarsus Group PLC
15 May 2012
 



15 May 2012

TARSUS GROUP plc

 

Interim Management Statement

 

Tarsus Group plc (LSE: TRS, "Tarsus" or the "Group"), the international business-to-business media group, is today publishing its Interim Management Statement for the period from 8 March 2012 to 14 May 2012.

 

Overview

 

Trading for the period has been in line with the Board's expectations and forward bookings for the year to 31 December 2012 now stand at 65% of anticipated full year revenues, compared to 61% at the same time in 2010.

 

Bookings are tracking 15% ahead of last year (as adjusted for biennial events). Revenues are heavily weighted towards the second half of the year owing to the timing of exhibitions.

 

The Group's growth prospects have been transformed over the last 12 months. A number of lower growth businesses have been sold whilst the Group has made key acquisitions in China and Turkey. Tarsus has developed a high quality portfolio of international fast growth events in emerging markets and the Board is confident of reaching its 50/13 target to derive 50% of revenues from emerging markets in 2013.

 

Emerging markets

 

The Group's emerging markets businesses continues to gain momentum through a combination of strong revenue growth and the successful integration of recent acquisitions.

 

IFO in Turkey, acquired in June 2011, is performing well. Sales for IFO's next exhibition, REW Istanbul, the international recycling, environmental technologies and waste management event to be held in June 2012, are tracking significantly ahead of the 2011 edition.

 

The integration of Life Media in Turkey, acquired in March 2012, is on track. Life Media's first exhibition under Tarsus ownership, Ideal Home, Turkey's leading Housewares & Gifts event, was held in April 2012 and produced an excellent performance with revenues up 50% on the 2011 edition.

 

Trading in the Chinese business continues to be very strong. The Group's exposure to China will be increased significantly by the acquisition of 50% of the China International Automotive Aftermarket Industry and Tuning (Guangzhou) Trade Fair ("GZ Auto") and other associated business assets, which is expected to complete in the next three months. GZ Auto is a leading business-to-business automotive aftermarket exhibition held annually in China. The joint venture will provide Tarsus with exposure to the vibrant automotive industry in China.

 

The Group's largest event in Dubai in 2012 is MEBA (business aviation). Forward bookings for this event are tracking ahead of the previous event.

 

US

 

The Medical division continues to grow strongly. This has been driven by its education programmes, including those now delivered online. The 20th Annual World Congress on Anti-Aging & Regenerative Medicine will be held in Orlando later this week and it is expected that this event will be well ahead of the previous edition. The Medical division's remaining 2012 order book is strong.

 

The February 2012 Off-Price Show in Las Vegas performed well, with revenues up 7%. Bookings for the August 2012 Off-Price Show in Las Vegas are tracking ahead of the 2011 edition.

 

Labelexpo Americas will be held in Chicago in September 2012. Bookings are strong and it is expected to outperform its previous edition.

 

Europe

 

Trading in the Group's French division has been slightly better than expected. However, given the current economic and political uncertainty in Europe, Tarsus remains cautious for the full year, particularly given the occurrence of the largest French shows in the second half of 2012 and the current weakness of the Euro.

 

Financial Position

 

There have been no significant changes to the financial position of the Group since the publication of the Annual Results on 7 March 2012.

 

 

Douglas Emslie, Tarsus Group Managing Director, said:

 

"We have transformed the Group and its growth prospects in the last 12 months through a combination of acquisitions in Turkey and China and the disposal of a significant part of our French operations - in line with our 50/13 strategy, which is now substantially complete.

 

"We now have a high quality portfolio addressing growth markets in fast growing economies worldwide. We are focussed on driving visitor traffic and growing exhibition volumes as we seek to maximise the benefits of our unique and diversified portfolio in order to accelerate earnings growth."

 

The Group expects to publish its interim results for the six months ending 30 June 2012 on 25 July 2012.

 

For further information:

 

Tarsus Group plc:

Douglas Emslie, Group Managing Director 020 8846 2700

Dan O'Brien, Group Finance Director

 

College Hill:

Adrian Duffield /Kay Larsen 020 7457 2020

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBKQDBABKDKPD
Date   Source Headline
16th May 20197:00 amRNSTrading Update
9th May 20196:19 pmRNSBlock Listing Six Monthly Return
30th Apr 201910:14 amRNSTotal Voting Rights
16th Apr 20192:40 pmRNSDirector/PDMR Shareholding
2nd Apr 20193:43 pmRNSBlock listing Interim Review
1st Apr 201910:44 amRNSTotal Voting Rights
19th Mar 201911:42 amRNS2018 Annual Report
8th Mar 20194:36 pmRNSPrice Monitoring Extension
27th Feb 20197:00 amRNSFinal Results
6th Feb 20194:35 pmRNSPrice Monitoring Extension
31st Jan 201911:53 amRNSTotal Voting Rights
30th Jan 20197:00 amRNSOption agreement re Tarsus Connect
16th Jan 20194:22 pmRNSApplication for Admission
14th Jan 20197:00 amRNSYear-end Trading Update
13th Dec 20184:48 pmRNSScrip Dividend Circular (the "Circular")
30th Nov 20183:10 pmRNSTotal Voting Rights
20th Nov 20181:44 pmRNSApplication for Admission
6th Nov 20187:00 amRNSCapital Markets Seminar and Trading Update
1st Nov 20182:56 pmRNSTotal Voting Rights
18th Sep 20186:20 pmRNSDirector/PDMR Shareholding
14th Sep 201812:06 pmRNSResults of Placing
14th Sep 20187:00 amRNSAcquisitions and Placing of New Ordinary Shares
10th Sep 20183:18 pmRNSBlock Listing Six Monthly Return
31st Aug 20183:39 pmRNSTotal Voting Rights
24th Aug 201811:17 amRNSHalf-year Report
1st Aug 201811:54 amRNSTotal Voting Rights
26th Jul 20187:00 amRNSHalf-year Report
13th Jul 20182:34 pmRNSApplication for Admission - scrip dividend shares
13th Jul 20182:18 pmRNSDirector Declaration
21st Jun 20181:52 pmRNSResult of AGM
18th Jun 20183:37 pmRNSHolding(s) in Company
12th Jun 20184:41 pmRNSDirector/PDMR Shareholding
8th Jun 20183:45 pmRNSScrip Dividend Circular
1st Jun 201812:31 pmRNSTotal Voting Rights
21st May 20186:10 pmRNSNotice of AGM
17th May 20187:00 amRNSTrading Update
9th May 20187:00 amRNSBlock Listing Six Monthly Return
9th May 20187:00 amRNSBoard Changes
1st May 201811:45 amRNSTotal Voting Rights and Capital
20th Apr 201812:15 pmRNSDirector/PDMR Shareholding
20th Apr 201812:14 pmRNSDirector/PDMR Shareholding
18th Apr 20184:29 pmRNSNotification of Transactions
29th Mar 201810:50 amRNSTotal Voting Rights
22nd Mar 20185:01 pmRNS2017 Annual Report
9th Mar 20183:54 pmRNSDirector/PDMR Shareholding
6th Mar 201810:18 amRNSBlock Listing Six Monthly Return
5th Mar 20185:06 pmRNSDirector/PDMR Shareholding
28th Feb 20187:00 amRNSFinal Results
31st Jan 20189:40 amRNSTotal Voting Rights
12th Jan 201810:30 amRNSApplication for Admission - scrip dividend shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.